Dr Gaurav Kumar trained for 10 years in different subspecialties within oncology, including Fellowship of the Royal College of Radiologist (FRCR) prior to substantive appointment as a consultant clinical oncologist at James Cook University Hospital in February 2016.
Dr Kumar was trained in all aspects of general oncology and currently works in a large secondary and tertiary cardiac centre with a referral population of > 1.3 million, covering radiotherapy and chemotherapy including immunotherapy and other forms of precision molecular targeted drug therapies. Dr Kumar regularly manage patients with malignant conditions including lung cancer, prostate and bladder cancers. Dr Kumar provides specialist services in cancer systemic therapy to three acute NHS Trusts. He also provides services as a private clinical oncologist at several hospitals.
Dr Kumar has vast clinical experience in treating lung and uro-oncology. Dr. Kumar has developed hypofractionation during COVID19 pandemic, including single fraction stereotactic radiotherapy (SABR) in lung cancers. He’s an active member of the trusts’ stereotactic ablative radiotherapy group. Dr Kumar is the clinical lead for prostate cancers in the trust. He’s heading the pilot project (‘’EARLY’’- Easy Access to Radical Lung cancer chemoradiotherapy) to streamline lung cancer treatment. He also leads the palliative radiotherapy pathway in the trust called ‘’PRISM’’ (Palliative Radiotherapy In-patient Service Management). He’s involved in clinical research, trials & teaching and has published peer reviewed articles in renowned medical journals.
Dr Kumar received training in proton therapy at the prestigious radiation oncology department of Perelman School of Medicine at the University of Pennsylvania in 2019.
Qualifications and appointments
- MB BS (Distinction), Maharashtra, India, 2005
- Diploma in Medical Radiotherapy (Gold medallist), Chennai, India, 2008
- Diplomat of National Board in Radiotherapy, New Delhi, India, 2010
- Consultant clinical oncologist, South Tees Hospitals NHS FT, 2016
Professional affiliations
- Fellow of the Royal College of Radiologists (FRCR)
- Member of the British Thoracic Oncology Group (BTOG)
- Member of the British Uro- Oncology Group (BUG)
- Member of the Medical and Dental Defence Union of Scotland (MDDUS)
- Member of the European Society for Therapeutic Radiology and Oncology (ESTRO)
- Member of the American Society for Therapeutic Radiology and Oncology (ASTRO)
- Member of the American Society of Clinical Oncology (ASCO)
Additional responsibilities
- Named clinical/educational supervisor by General Medical Council (GMC)
- Named clinical/educational supervisor for medical graduates & postgraduate trainees
- Principal Investigator on multiple research studies (e.g. KEYNOTE905, GUSTO, SPRUCE, PIVOTAL BOOST)
- Significant publication record
Special interests
- Stereotactic Ablative Body Radiotherapy (SABR / SBRT)
- Immuno Oncology
- Targeted and Precision medicine
- Proton Therapy
- Research, training, medical education
Additional specialties and subspecialties
- Oncology
- thoracic oncology
- uro-oncology
- immuno-oncology
- chemotherapy
- targeted therapy
- precision medicine
- stereotactic radiotherapy
- Intensity Modulated Radiotherapy (IMRT)
- Image guided radiotherapy (IGRT)
- Volumetric Arc Therapy (VMAT)
- proton therapy
- international and national clinical trials – evaluating novel therapies and different forms of complex radiotherapy applications.